Medical resource use and costs among rheumatoid arthritis patients receiving disease-modifying antirheumatic drug therapy.

OBJECTIVE: To identify costs among rheumatoid arthritis (RA) patients receiving alternative disease-modifying antirheumatic drug (DMARD) therapies. METHODS: Using managed care organization data, we identified members who (a) were prescribed any DMARD therapy for two consecutive months between July 1...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính: Griffiths, R, Bar-Din, M, MacLean, C, Sullivan, E, Herbert, R, Yelin, E
Định dạng: Journal article
Ngôn ngữ:English
Được phát hành: 2000